USPTO serial 88922034
KANTARO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 8, 2022
- Examiner
- PURATH, ANICKA S
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with KANTARO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michelle A. Cooke
Michelle A. Cooke MANATT, PHELPS & PHILLIPS, LLP2049 CENTURY PARK EAST, SUITE 1700LOS ANGELES, CA 90067UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medical diagnostic reagents and assays for testing and analysis of blood, bodily fluids, biological and cellular samples and specimens and tissue; Assays, reagents, solutions, buffers and preparations for medical, clinical and diagnostic use; Diagnostic agents for carrying out serologic tests for medical purposes; Diagnostic reagents for serologic tests of infections for medical purposes; Diagnostic agents, preparations, substances and diagnostic test kits primarily comprised of medical diagnostic reagents and assays, and also consisting of vessels, containers and implements being medical specimen collection and processing devices in the nature of tubes, swabs, bags, vials, laboratory bottles, cups, and laboratory pipettes for the collection and processing of blood, bodily fluids, biological and cellular samples and specimens and body tissue for performing serological and molecular tests, used for detecting antibodies, enzymes, antigens, diseases, viruses and infections for medical, clinical and research purposes; Test kits consisting of medical diagnostic reagents, assays, solutions and buffers for testing in the field of the prevention and treatment of infections, viruses, disorders and diseases; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of blood, bodily fluids, biological and cellular samples and specimens and tissue for use in infection, virus and disease detection, namely, infectious, viral, communicable, blood borne pathogen, vector borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Antibody diagnostic test for use in disease detection; Medical diagnostic test kits comprised of medical diagnostic assays, reagents, media, solutions in the nature of reagent solutions, substrate solutions, stop solutions, staining solutions, standard solutions and buffer solutions, buffers and diagnostic preparations for coronavirus, SARS-CoV-2 and COVID-19 diagnosis and monitoring | ACTIVE | Aug 28, 2020 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Kantaro Biosciences LLC
- Other trademarks owned by Kantaro Biosciences LLC
- Other trademarks owned by Kantaro Biosciences LLC
- Other trademarks in Class 005
- Similar marks named KANTARO
- Prosecution event R.PR explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 8, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 1, 2022 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Jan 31, 2022 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Jan 28, 2022 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jan 28, 2022 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jan 13, 2022 | IUAF | USE AMENDMENT FILED | — |
| Jan 13, 2022 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jul 13, 2021 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 18, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 18, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 28, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 13, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 13, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 13, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 13, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 13, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 1, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 1, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 26, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 26, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 8, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 8, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 8, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 7, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 3, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 21, 2020 | NWAP | NEW APPLICATION ENTERED | — |